Novo Nordisk's CEO Lars Fruergaard Jørgensen defends the high prices of Wegovy and Ozempic during a US Senate hearing.

: A new study reveals that blood tests for Alzheimer's can diagnose the disease with 90% accuracy in real-world healthcare settings.